Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial.
Fan L, Zhang WJ, Li HP, Zeng XH, Teng YE, Gong Y, Jin X, Zhao S, Sun T, Chen WY, Wang SS, Yang J, Zhuang ZG, Ni SJ, He ZX, Fu DY, Song CG, Lv Z, Liang QN, Yu BH, Shi J, Wang N, Liang XR, Zhang NN, Wang Y, Ji P, Liu XY, Chen L, He M, Liu Y, Sui XY, Ma LX, Zhu XZ, Yang F, Ge LP, Wu SY, Wu J, Yu KD, Liu GY, Hu X, Shen Y, Pang Z, Wang JF, Liang F, Yang WT, Wang ZH, Jiang YZ, Shao ZM; BCTOP investigators.
Fan L, et al.
Cancer Cell. 2026 Feb 9;44(2):355-365.e3. doi: 10.1016/j.ccell.2025.11.003. Epub 2025 Dec 4.
Cancer Cell. 2026.
PMID: 41349543
Clinical Trial.